Membrane saturated fatty acids and disease progression in Multiple Sclerosis patients

Metabolic Brain Disease

Volumn 24, Issue 4, 2009, Pages 561-568

  Hon, G M ^a   Hassan, M S ^a   Van Rensburg, S J ^b   Abel, S ^c   Erasmus, R T ^d   Matsha, T ^a  

^a CAPE PENINSULA UNIVERSITY OF TECHNOLOGY   (South Africa)

^b NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^c South African Research Council   (South Africa)

^d STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

C reactive protein; Expanded disability status scale; Multiple sclerosis; Saturated fatty acids

Indexed keywords

C REACTIVE PROTEIN; SATURATED FATTY ACID;

ADULT; ARTICLE; BLOOD SAMPLING; CELL MEMBRANE; CLINICAL ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; DISEASE COURSE; DISEASE SEVERITY; ERYTHROCYTE MEMBRANE; EXPANDED DISABILITY STATUS SCALE; FAT INTAKE; FEMALE; GAS CHROMATOGRAPHY; HUMAN; LIPID COMPOSITION; MALE; MULTIPLE SCLEROSIS; PERIPHERAL BLOOD MONONUCLEAR CELL;

ADULT; BIOLOGICAL MARKERS; CAUSALITY; DIETARY FATS; DISABILITY EVALUATION; DISEASE PROGRESSION; ERYTHROCYTES; FATTY ACIDS; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MEMBRANE LIPIDS; MIDDLE AGED; MOLECULAR WEIGHT; MULTIPLE SCLEROSIS; PHOSPHATIDYLINOSITOLS; SPHINGOMYELINS;

EID: 74449086140     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11011-009-9159-0     Document Type: Article

References (31)

1. A Antonovsky U Leibowitz HA Smith JM Medalie M Balogh R Kats L Halpern M Alter 1965 Epidemiologic study of multiple sclerosis in Israel Arch Neurol 13 183 193 1:STN:280:DyaF2M7itVegsg%3D%3D 14315670
2. JM Boggs MA Moscarello 1980 A comparison of composition and fluidity of multiple sclerosis and normal myelin Neurochem Res 5 319 336 10.1007/BF00964620 1:CAS:528:DyaL3cXktVGnu70%3D 6246464
3. KA Brown 2001 Factors modifying the migration of lymphocytes across the blood-brain barrier Int Immunopharmacol 1 2043 2062 10.1016/S1567-5769(01)00129- 1 1:CAS:528:DC%2BD3MXotFamsbs%3D 11710535 (Pubitemid 32973698)
4. W Brück 2005 Clinical implications of neuropathological findings in multiple sclerosis J Neurol 252 III/10 III/14 10.1007/s00415-005-2011-5 (Pubitemid 41355779)
5. PJ Butcher 1986 Milk consumption and multiple sclerosis-an etiological hypothesis Med Hypotheses 19 169 178 10.1016/0306-9877(86)90057-5 1:STN:280:DyaL283gtlSjtg%3D%3D 3634908 (Pubitemid 16130771)
6. W Cendrowski M Wender W Dominik Z Flejsierowicz M Owsianowski M Popiel 1969 Epidemiological study of multiple sclerosis in Western Poland Eur Neurol 2 90 108 10.1159/000113777 1:STN:280:DyaF1M3mt1Grsw%3D%3D 5819891
7. GD Cherayil 1984 Sialic acid and fatty acid concentrations in lymphocytes, red blood cells and plasma from patients with multiple sclerosis J Neurol Sci 63 1 10 10.1016/0022-510X(84)90104-7 1:STN:280:DyaL2c7jslOhsA%3D%3D 6699649 (Pubitemid 14178549)
8. RL Cooper 1997 Multiple sclerosis: an immune legacy? Med Hypotheses 49 307 311 10.1016/S0306-9877(97)90196-1 1:CAS:528:DyaK2sXnsV2jsL4%3D (Pubitemid 27451881)
9. SM Cordo NA Candurra EB Damonte 1999 Myristic acid analogs are inhibitors of Junin virus replication Microb Infect 1 609 614 10.1016/S1286-4579(99)80060- 4 1:CAS:528:DyaK1MXmt12gtb0%3D
10. SC Cunnane S-Y Ho P Dore-Duffy KR Ells DF Horrobin 1989 Essential fatty acid and lipid profiles in plasma and erythrocytes in patients with multiple sclerosis Am J Clin Nutr 50 801 806 1:STN:280:DyaK3c%2Fitlejuw%3D%3D 2801584
11. J Folch M Lees GH Sloane-Stanley 1957 A simple method for the isolation and purification of total lipids from animal tissues J Biol Chem 226 497 509 1:STN:280:DyaG2s%2FnsFCjtw%3D%3D 13428781
12. JB German CJ Dillard 2004 Saturated fats: what dietary intake? Am J Clin Nutr 80 550 559 1:CAS:528:DC%2BD2cXnsVWiur4%3D 15321792
13. RJA Grand 1989 Acylation of viral and eukaryotic proteins Biochemistry 258 625 638 1:CAS:528:DyaL1MXhvVOrsb0%3D
14. LS Harbige MK Sharief 2007 Polyunsaturated fatty acids in the pathogenesis and treatment of multiple sclerosis Br J Nutr 98 S46 S53 10.1017/S0007114507833010 1:CAS:528:DC%2BD2sXhtlGmtr%2FK 17922959 (Pubitemid 47543477)
15. RT Holman SB Johnson E Kokmen 1989 Deficiencies of polyunsaturated fatty acids and replacement by nonessential fatty acids in plasma lipids in multiple sclerosis Proc Natl Acad Sci USA 86 4720 4724 10.1073/pnas.86.12.4720 1:CAS:528:DyaL1MXkslGrsLk%3D 2734316
16. GM Hon MS Hassan SJ Van Rensburg S Abel W De Marais P Van Jaarsveld CM Smuts F Henning RT Erasmus T Matsha 2009 Erythrocyte membrane fatty acids in patients with multiple sclerosis Mult Scler 15 759 762 10.1177/1352458509103321 1:CAS:528:DC%2BD1MXovFOrsr0%3D 19435752
17. G Hon M Hassan SJ Van Rensburg S Abel DW Marais P Van Jaarsveld C Smuts F Henning R Erasmus T Matsha 2009 Immune cell membrane fatty acids and inflammatory marker, C-reactive protein, in patients with multiple sclerosis Br J Nutr 19 1 7
18. SF Hunter DA Hafler 2000 Ubiquitous pathogens. Links between infection and autoimmunity in MS? Neurology 55 164 165 1:STN:280:DC%2BD3czpvValtg%3D%3D 10908883
19. V Kaushal LD Barnes 1986 Effect of zwitterionic buffers on measurement of small masses of protein with bicinchoninic acid Anal Biochem 157 291 294 10.1016/0003-2697(86)90629-9 1:CAS:528:DyaL28XlvVKqur0%3D 3777432
20. JF Kurtzke 1983 Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS) Neurology 33 1444 1452 1:STN:280:DyaL2c%2FktValsQ%3D%3D 6685237
21. B Narasimhan V Mourva A Dhake 2006 Design, synthesis, antibacterial, and QSAR studies of myristic acid derivatives Bioorg Med Chem Lett 16 3023 3029 10.1016/j.bmcl.2006.02.056 1:CAS:528:DC%2BD28XjvFygtb8%3D 16554156
22. X Navarro R Segura 1989 Red blood cell fatty acids in multiple sclerosis Acta Neurol Scand 79 32 37 10.1111/j.1600-0404.1989.tb03706.x 1:STN:280:DyaL1M7ovFKitA%3D%3D 2929272
23. K Okubo N Hamasaki K Hara M Kageura 1991 Palmitoylation of cysteine 69 from the COOH-terminal of Band 3 protein in the human erythrocyte membrane J Biol Chem 266 16420 16424 1:CAS:528:DyaK3MXmtVWguro%3D 1885574
24. JA Sands 1977 Inactivation and inhibition of replication of the enveloped bacteriophage φ6 by fatty acids Antimicrob Agents Chemother 12 523 528 1:CAS:528:DyaE1cXivVGq 921248
25. P Stinissen J Raus J Zhang 1997 Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphocytes and new immunotherapeutic strategies Crit Rev Immunol 17 33 75 1:CAS:528:DyaK2sXhsVOntr0%3D 9034723
26. PJ Van Jaarsveld CM Smuts HY Tichelaar M Kruger AJS Benadé 2000 Effect of palm oil on plasma lipoprotein concentrations and plasma low-density lipoprotein composition in non-human primates Int J Food Sci Nutr 51 S21 S30 10.1080/096374800750049549 11271853
27. ME Van Meeteren CE Teunissen CD Dijkstra EA Van Tol 2005 Antioxidants and polyunsaturated fatty acids in multiple sclerosis Eur J Clin Nutr 59 1347 61 10.1038/sj.ejcn.1602255 16118655 (Pubitemid 43135149)
28. SA Warren KG Warren S Greenhill M Paterson 1982 How multiple sclerosis is related to animal illness, stress and diabetes Can Med Assoc J 126 377 385 1:STN:280:DyaL387mt1amtg%3D%3D 7066795
29. KB Westlund LT Kurland 1953 Studies on multiple sclerosis in Winnipeg, Manitoba, and New Orleans Louisiana Am J Hyg 57 397 407 1:STN:280: DyaG3s%2FmsFSktg%3D%3D
30. N Zamaria 2004 Alteration of polyunsaturated fatty acid status and metabolism in health and disease Reprod Nutr Dev 44 273 82 10.1051/rnd:2004034 1:CAS:528:DC%2BD2cXoslGlsbk%3D 15460166 (Pubitemid 39198969)
31. SM Zhang WC Willett MA Hernán MJ Olek A Ascherio 2000 Dietary fat in relation to risk of multiple sclerosis among two large cohorts of women Am J Epidemiol 152 1056 64 10.1093/aje/152.11.1056 1:STN:280:DC%2BD3M%2FntVGjtg%3D%3D 11117615